Aptabio Therapeutics Inc (XKRX:293780)
â‚© 6200 -320 (-4.91%) Market Cap: 138.25 Bil Enterprise Value: 113.96 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 52/100

Aptabio Therapeutics Inc (XKRX:293780) Transcripts

    • 1